CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
NCT05896813
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Newly Diagnosed Peripheral T-cell Lymphoma
Interventions
DRUG:
CMOP+Chidamide
Sponsor
The First Affiliated Hospital with Nanjing Medical University